[ET Net News Agency, 17 January 2024] REMEGEN (09995) fell 20.3% to HK$25.05.
It hits an intra-day low of HK$25, hitting a historical low, and an intra-day high of
HK$31.5. The total shares traded was 3.84 million, with a value of HK$105.54m. The active
buy/sell ratio is 30:70, with net selling turnover of HK$39.78m. CHINA INV INFO accounts
for greatest net responsive buying turnover of HK$10.59m, with volume weighted average
price of HK$27.897. CHINA INNOVATION MARKET SER accounts for greatest net responsive
selling turnover of HK$2.45m, with volume weighted average price of HK$27.425. The stock
has fallen a combined 23.4% over the past 2 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 25.050 % Chg -20.35%
High 31.500 Low 25.000
Shares Tr 3.84m Turnover 105.54m
10-D SMA 32.345 %H.V 56.328
20-D SMA 33.682 VWAP 27.500
50-D SMA 39.155 RSI14 24.237
----------------------------------
Status: Hitting a historical low, active buy/sell ratio is 30:70, with net selling
turnover of HK$39.78m, falling a combined 23.4% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 25.05 -20.35
HUTCHMED (00013) 24.05 -6.05
GENSCRIPT BIO (01548) 17.36 -5.14
INNOVENT BIO (01801) 38.90 -4.19
JXR (01951) 2.61 -4.40
EVEREST MED-B (01952) 18.30 -4.19
KEYMED BIO-B (02162) 38.45 -5.88
WUXI BIO (02269) 29.00 -4.76
BEIGENE (06160) 98.85 -3.75
AKESO (09926) 44.60 -5.61
---------------------------------------------
(ed)